Produkty 79037-34-6

CAS 79037-34-6 występuje w naszej ofercie pod nazwami: Androstanolone-d3, Androstanolone-d3 (1.0 mg/ml in Methanol), 5alpha-Androstan-17beta-ol-3-one-16,16,17-d3, 98 atom % D, min 98% Chemical Purity. Oferty producentów: TRC, CDN. Dostępne opakowania: 1mg, 2,5mg, 1x1ml, 0,05g, 0,01g.

Androstanolone-d3
TRC
  • opakowanie: 1mg, 2,5mg
  • Warianty: 2
Zobacz produkt
Androstanolone-d3 (1.0 mg/ml in Methanol)
TRC
  • opakowanie: 1x1ml
  • Warianty: 1
Zobacz produkt
5alpha-Androstan-17beta-ol-3-one-16,16,17-d3, 98 atom % D, min 98% Chemical Purity
CDN
  • opakowanie: 0,05g, 0,01g
  • Warianty: 2
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(5S,9S,10S,13S,14S,17S)-16,16,17-trideuterio-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15-dodecahydrocyclopenta[a]phenanthren-3-one (CAS 79037-34-6) to związek chemiczny o wzorze sumarycznym C19H30O2 i masie molowej 293.5 g/mol. Nazwa systematyczna IUPAC: (5S,9S,10S,13S,14S,17S)-16,16,17-trideuterio-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15-dodecahydrocyclopenta[a]phenanthren-3-one. InChIKey: NVKAWKQGWWIWPM-NWQJCVHWSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H30O2
Masa molowa293.5 g/mol
Nazwa IUPAC(5S,9S,10S,13S,14S,17S)-16,16,17-trideuterio-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15-dodecahydrocyclopenta[a]phenanthren-3-one
InChIKeyNVKAWKQGWWIWPM-NWQJCVHWSA-N
SMILES[2H][C@]1([C@]2(CC[C@H]3C([C@@H]2CC1([2H])[2H])CC[C@@H]4[C@@]3(CCC(=O)C4)C)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Dihydrotestosterone-d3 Solution in Methanol, 100ug/mL, Dihydrotestosterone-d3 Solution in Methanol, 10ug/mL, 17beta-Hydroxy(16,16,17-~2~H_3_)-5alpha,8xi-androstan-3-one, (5alpha,8xi,17beta)-17-Hydroxy(16,16,17-~2~H_3_)androstan-3-one
Powiązane formy tego związku
(5S,8R,9S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C19H30O2
(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C19H30O2
(5S,8R,9S,10S,13S,14S,17S)-2,2,4,4-tetradeuterio-17-hydroxy-10,13-dimethyl-1,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H30O2
(5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C19H30O2
(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C19H30O2
Izomery (ten sam wzór sumaryczny)
nonadeca-2,4-diynoic acid C19H30O2
dodecyl benzoate C19H30O2
4-dodecoxybenzaldehyde C19H30O2
4-dodecylbenzoic acid C19H30O2
2,4,6-tritert-butylbenzoic acid C19H30O2
methyl (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate C19H30O2
(3S,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O2